Darnytsia and the Heart Institute of the Ministry of Health of Ukraine Join Forces for the Health of Ukrainians’ Hearts – Highlights of the “Modern Cardiology-2025” Conference
Darnytsia Pharmaceutical Company, together with the Heart Institute of the Ministry of Health of Ukraine, held a unique conference for cardiologists, cardiac surgeons, and family doctors — “Modern Cardiology-2025.”
The event became a platform for discussing the most relevant news in the world of cardiology, exchanging experience, and searching for new effective solutions to improve treatment methods for patients with cardiovascular diseases.
The conference brought together more than 500 doctors from across the country and featured over 15 powerful presentations by Ukrainian and international speakers.
Cardiology is a highly relevant topic today. According to official data from the Ministry of Health of Ukraine, cardiovascular diseases remain the leading cause of death in the country. In recent years, about 65% of all deaths in Ukraine have been caused by cardiovascular diseases. Every year, more than 350,000 Ukrainians die from such diseases.
During the event, participants learned about all aspects of providing cardiological care — from prevention to complex surgical interventions.
In particular, the conference addressed trends in modern heart transplantation, treatment of end-stage heart failure, atherosclerosis, asymptomatic heart arrhythmias, ischemic heart disease, and many other dangerous conditions.
Doctors also had the opportunity to learn about the current state of cardio-oncology worldwide, modern possibilities of minimally invasive cardiac surgery, the use of AI, and the latest technologies in surgery.
The conference also focused on modern methods of treating combat injuries and pediatric transplantation.
Much attention was paid to the prevention of cardiovascular diseases. In this context, proper nutrition is important. That is why the “Strong Hearts” initiative was presented at the conference. Its representatives treated guests to a healthy smoothie based on a recipe by Nataliia Suslova, PhD, medical director of the “Strong Hearts” foundation, Grace clinic, and founder of the educational platform “Biochemical Clinical Hub.”
During the event, Darnytsia presented social programs for patients. Conference participants had the opportunity to join each program to provide their patients with necessary medicines at a discount, thus increasing adherence to therapy and ensuring high-quality treatment from the leader of pharmaceutical manufacturing in Ukraine.
“The support of our partners from Darnytsia is not just about medicines, but about true teamwork for the sake of life. We have felt this help since the first day of the war — in science, treatment, and humanitarian projects. It is thanks to the unification of efforts that we can save more lives and implement the latest technologies,” said Professor Borys Todurov, General Director of the Heart Institute of the Ministry of Health of Ukraine.
“We strive to break stereotypes: a Ukrainian pharmaceutical company can produce high-quality, effective medicines. We use premium raw materials, and our products undergo clinical trials and have international quality certificates. We were the first in Ukraine to receive a GMP certificate, and today we have confirmed it in the EU and Australia. Most Ukrainians who found themselves abroad realized that Ukrainian doctors provide high-quality services. At the same time, Ukrainian medicines are in no way inferior to foreign ones in terms of quality, effectiveness, and safety,” emphasized Svitlana Maksymova, Rx Sales & Marketing Department Director at Darnytsia Pharmaceutical Company.